search
Back to results

mHealth Intervention to Prevent Type 2 Diabetes Mellitus (Phase II Study) (preDIABETEXT)

Primary Purpose

Prediabetic State

Status
Enrolling by invitation
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
preDIABE-TEXT
Online Education
Sponsored by
Fundació d'investigació Sanitària de les Illes Balears
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Prediabetic State focused on measuring Prediabetic State, Glycemic Control, Telemedicine

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

ELIGIBILITY CRITERIA FOR PRIMARY HEALTHCARE WORKERS:

We will include physicians and nurses from primary care centres in Mallorca. We will exclude those anticipating moving to a different centre during the study period.

ELIGIBILITY CRITERIA FOR PATIENTS:

Inclusion Criteria:

  • Registered in the Public Health Service of the Balearic Islands
  • At risk of T2DM (HbA1c from 6% to 6.4% within the last 3 months or two consecutive values of fasting plasma glucose 110-125mg/dl within the last 12 months, or both)
  • With access to a mobile device able to receive text messages.

Exclusion Criteria:

  • People not able to read messages in Spanish
  • Patients with severe mental conditions.
  • Patients on an antidiabetic medication regime
  • Pregnancy: currently or during the previous 12 months
  • People planning to change healthcare centre during the intervention period

Sites / Locations

  • Ignacio Ricci-Cabello

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

No Intervention

Arm Label

Intervention A

Intervention B

Control

Arm Description

Participants will receive Messaging Intervention

Participants will receive messaging intervention plus online education to their primary healthcare workers

Participants will receive usual care only, and their healthcare workers will not receive online education

Outcomes

Primary Outcome Measures

Change from Baseline Glycated Hemoglobin (HbA1C) at 6 months

Secondary Outcome Measures

Change from Baseline Fasting blood glucose at 6 months
Change from Baseline Triglycerides at 6 months
Change from Baseline Total Cholesterol at 6 months
Change from Baseline low density cholesterol (LDL) at 6 months
Change from Baseline high density cholesterol (HDL) at 6 months
Change from Baseline lipoprotein A at 6 months
Change from Baseline aspartate aminotransferase enzyme (AST) at 6 months
Change from Baseline alanine aminotransferase (ALT) at 6 months
Change from Baseline gamma glutamil transpeptidase (GGT) at 6 months
Change from Baseline complete hemogram at 6 months
Change from Baseline creatinine at 6 months
Change from Baseline serum albumin at 6 months
Change from Baseline insuline at 6 months
Change from Baseline urinary sediment at 6 months
Change from Baseline albumin-craetinine ratio at 6 months
Change from Baseline Body Weight at 6 months
Change from Baseline Waist Circumference at 6 months
Change from Baseline Blood Pressure at 6 months
Change from Baseline of Cardiovascular disease risk at 6 months
Cardiovascular disease risk determined using the REGICOR calculator (www.imim.cat; Ramos et al., 2003)
Diagnosis of T2DM
Brief motivation questionnaire (ad hoc)
On a scale from 0 to 7, this questionnaire meassures the level of motivation that participants present for following a healthy diet and a physical activity plan.
14-point Mediterranean diet adherence screener (MEDAS-14)
Adherence to healthy diet. The score ranges from 0 to 14. A higher score corresponds to a higher adherence to Mediterranean diet. We will classify participants as low adherents (≤5), moderate adherents (6-9) or high adherents (≥10).
REGICOR Short form Physical Activity Questionnaire
The questionnaire is a reliable and valid method to estimate moderate and vigorous intensity leisure time physical activity and sensitive to detect changes in moderate and vigorous intensity leisure time physical activity https://regicor.cat/aplicacions/activitat-fisica/
Spanish version of the physical activity questionnaire used in the Physical activity questionnaire from the Nurses' Health Study
We will use the second part of the questionnaire, which studies sedentary behaviour. It includes questions about the number of hours spent in sedentary activities. Public Health Nutrition: 8(7), 920-927 https://nurseshealthstudy.org/
Global Adult Tobbacco Survey: GATS questionnaire.
Tobbacco consumption. 3-items adapted from the GATS questionnaire (WHO).
Quantification of alcohol consumption - FISTERRA
Calcultaion of alcohol consumption in Spanish Standard Drink units (10g per unit) per week. https://www.fisterra.com/herramientas/calcumed/

Full Information

First Posted
October 5, 2021
Last Updated
August 12, 2022
Sponsor
Fundació d'investigació Sanitària de les Illes Balears
search

1. Study Identification

Unique Protocol Identification Number
NCT05110625
Brief Title
mHealth Intervention to Prevent Type 2 Diabetes Mellitus (Phase II Study)
Acronym
preDIABETEXT
Official Title
Development and Evaluation of a Low Intensity, Multifaceted, Digital Health Intervention to Prevent Type 2 Diabetes Mellitus in the Primary Care Setting: the PREDIABETEXT Study
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Enrolling by invitation
Study Start Date
December 1, 2021 (Actual)
Primary Completion Date
January 31, 2023 (Anticipated)
Study Completion Date
January 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fundació d'investigació Sanitària de les Illes Balears

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to develop and evaluate a low intensity, multifaceted, digital health intervention to prevent T2DM based on: i) the use of a system comprising mobile health (mHealth) technology integrated with electronic health records to send tailored text messages (SMSs) promoting lifestyle changes in people at risk of T2DM, and, ii) the provision of online education to primary healthcare workers about prediabetes management.
Detailed Description
The PREDIABETEXT project will involve five WorkPackages (WP). In WP1-4 we will develop and pilot-test the different components of the intervention (WP1 will develop the brief text messages targeted to patients; WP2 will adapt our existing technology system to deliver the messages; WP3 will develop an educational intervention targeted to Primary Healthcare workers, and; WP4 will pilot-test and optimise both interventions). In WP5 we will conduct a phase II, six-month, three-arm, cluster randomised, clinical trial with 42 primary care workers and 420 patients at risk of T2DM (HbA1c from 6% to 6.4% or fasting plasma glucose 110-125mg/dl, or both) registered in Primary Care centres from Mallorca. Patients will be allocated to a control (usual care) group, intervention A (patient messaging intervention), or intervention B (patient messaging intervention plus online education to their primary healthcare workers). The primary outcome will be HbA1c. Secondary outcomes will include additional clinical outcomes, and physiological, behavioural and psychological outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prediabetic State
Keywords
Prediabetic State, Glycemic Control, Telemedicine

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
420 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention A
Arm Type
Experimental
Arm Description
Participants will receive Messaging Intervention
Arm Title
Intervention B
Arm Type
Experimental
Arm Description
Participants will receive messaging intervention plus online education to their primary healthcare workers
Arm Title
Control
Arm Type
No Intervention
Arm Description
Participants will receive usual care only, and their healthcare workers will not receive online education
Intervention Type
Behavioral
Intervention Name(s)
preDIABE-TEXT
Intervention Description
Participants will receive text messages (three per week) in their mobile phones during six months.
Intervention Type
Other
Intervention Name(s)
Online Education
Intervention Description
Primary healthcare workers will receive an online educacion about prediabetes. This intervention will aim at: 1) raising awareness about the importance of T2DM prevention; 2) increasing knowledge about effective strategies for diabetes prevention; 3) improving knowledge about brief counselling techniques; and, 4) enhancing communication skills.
Primary Outcome Measure Information:
Title
Change from Baseline Glycated Hemoglobin (HbA1C) at 6 months
Time Frame
Baseline and Postintervention (6 months)
Secondary Outcome Measure Information:
Title
Change from Baseline Fasting blood glucose at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline Triglycerides at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline Total Cholesterol at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline low density cholesterol (LDL) at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline high density cholesterol (HDL) at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline lipoprotein A at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline aspartate aminotransferase enzyme (AST) at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline alanine aminotransferase (ALT) at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline gamma glutamil transpeptidase (GGT) at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline complete hemogram at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline creatinine at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline serum albumin at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline insuline at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline urinary sediment at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline albumin-craetinine ratio at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline Body Weight at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline Waist Circumference at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline Blood Pressure at 6 months
Time Frame
Baseline and Postintervention (6 months)
Title
Change from Baseline of Cardiovascular disease risk at 6 months
Description
Cardiovascular disease risk determined using the REGICOR calculator (www.imim.cat; Ramos et al., 2003)
Time Frame
Baseline and Postintervention (6 months)
Title
Diagnosis of T2DM
Time Frame
Postintervention (6 months)
Title
Brief motivation questionnaire (ad hoc)
Description
On a scale from 0 to 7, this questionnaire meassures the level of motivation that participants present for following a healthy diet and a physical activity plan.
Time Frame
Baseline and Postintervention (6 months)
Title
14-point Mediterranean diet adherence screener (MEDAS-14)
Description
Adherence to healthy diet. The score ranges from 0 to 14. A higher score corresponds to a higher adherence to Mediterranean diet. We will classify participants as low adherents (≤5), moderate adherents (6-9) or high adherents (≥10).
Time Frame
Baseline and Postintervention (6 months)
Title
REGICOR Short form Physical Activity Questionnaire
Description
The questionnaire is a reliable and valid method to estimate moderate and vigorous intensity leisure time physical activity and sensitive to detect changes in moderate and vigorous intensity leisure time physical activity https://regicor.cat/aplicacions/activitat-fisica/
Time Frame
Baseline and Postintervention (6 months)
Title
Spanish version of the physical activity questionnaire used in the Physical activity questionnaire from the Nurses' Health Study
Description
We will use the second part of the questionnaire, which studies sedentary behaviour. It includes questions about the number of hours spent in sedentary activities. Public Health Nutrition: 8(7), 920-927 https://nurseshealthstudy.org/
Time Frame
Baseline and Postintervention (6 months)
Title
Global Adult Tobbacco Survey: GATS questionnaire.
Description
Tobbacco consumption. 3-items adapted from the GATS questionnaire (WHO).
Time Frame
Baseline and Postintervention (6 months)
Title
Quantification of alcohol consumption - FISTERRA
Description
Calcultaion of alcohol consumption in Spanish Standard Drink units (10g per unit) per week. https://www.fisterra.com/herramientas/calcumed/
Time Frame
Baseline and Postintervention (6 months)
Other Pre-specified Outcome Measures:
Title
Number of eligible patients
Time Frame
Baseline
Title
Recruitment rate
Description
follow-up rate
Time Frame
Baseline
Title
Follow-up rate
Time Frame
Postintervention (6 months)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
ELIGIBILITY CRITERIA FOR PRIMARY HEALTHCARE WORKERS: We will include physicians and nurses from primary care centres in Mallorca. We will exclude those anticipating moving to a different centre during the study period. ELIGIBILITY CRITERIA FOR PATIENTS: Inclusion Criteria: Registered in the Public Health Service of the Balearic Islands At risk of T2DM (HbA1c from 6% to 6.4% within the last 3 months or two consecutive values of fasting plasma glucose 110-125mg/dl within the last 12 months, or both) With access to a mobile device able to receive text messages. Exclusion Criteria: People not able to read messages in Spanish Patients with severe mental conditions. Patients on an antidiabetic medication regime Pregnancy: currently or during the previous 12 months People planning to change healthcare centre during the intervention period
Facility Information:
Facility Name
Ignacio Ricci-Cabello
City
Palma De Mallorca
State/Province
Balearic Islands
ZIP/Postal Code
07002
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
We will share all collected IPD after anonymization
IPD Sharing Time Frame
Data will be available from January 2023 onwards
IPD Sharing Access Criteria
Upon a reasonable request, we will grant access to public organizations. The PI of the project will review the requests.
Citations:
PubMed Identifier
21987347
Citation
Soriguer F, Goday A, Bosch-Comas A, Bordiu E, Calle-Pascual A, Carmena R, Casamitjana R, Castano L, Castell C, Catala M, Delgado E, Franch J, Gaztambide S, Girbes J, Gomis R, Gutierrez G, Lopez-Alba A, Martinez-Larrad MT, Menendez E, Mora-Peces I, Ortega E, Pascual-Manich G, Rojo-Martinez G, Serrano-Rios M, Valdes S, Vazquez JA, Vendrell J. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2012 Jan;55(1):88-93. doi: 10.1007/s00125-011-2336-9. Epub 2011 Oct 11.
Results Reference
background
PubMed Identifier
26393848
Citation
Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, Jan S, Graves N, de Keizer L, Barry T, Bompoint S, Stepien S, Whittaker R, Rodgers A, Thiagalingam A. Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease: A Randomized Clinical Trial. JAMA. 2015 Sep 22-29;314(12):1255-63. doi: 10.1001/jama.2015.10945. Erratum In: JAMA. 2016 Mar 8;315(10):1057.
Results Reference
background

Learn more about this trial

mHealth Intervention to Prevent Type 2 Diabetes Mellitus (Phase II Study)

We'll reach out to this number within 24 hrs